BrainEver

BrainEver and 3P Biopharmaceuticals Collaborate on Development of Recombinant Human Homeoprotein Engrailed-1

No·in, Spain, November 15, 2022: 3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in the process development and cGMP manufacturing of biological products and BrainEver a French biotechnology company focusing on discovering and developing First-in-Class therapies for the treatment of neurodegenerative diseases have entered into a long term collaboration to develop...
74, rue du Faubourg Saint-Antoine, 75012 Paris

810 542 506 000 11